Gland Pharma

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue1,4651,4431,4691,5631,571
Expenses1,2091,1431,1811,2501,287
EBITDA356.72418.45391.54425.29398.05
EBIT262.89322.12295.78324.24291.74
Profit Before Tax256.78299.30288.33312.74283.91
Net Profit163.53204.69186.54215.48183.68
Financial Ratios
Operating Profit Margin25.37%30.23%27.48%28.25%26.77%
Net Profit Margin11.63%14.79%13.09%14.31%12.35%
Earning Per Share (Diluted)9.9312.4211.3213.0811.15
Dividends Per Share0.000.000.000.000.00